1. Home
  2. BNTC vs BWMX Comparison

BNTC vs BWMX Comparison

Compare BNTC & BWMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • BWMX
  • Stock Information
  • Founded
  • BNTC 1995
  • BWMX 1995
  • Country
  • BNTC United States
  • BWMX Mexico
  • Employees
  • BNTC N/A
  • BWMX N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • BWMX Catalog/Specialty Distribution
  • Sector
  • BNTC Health Care
  • BWMX Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • BWMX Nasdaq
  • Market Cap
  • BNTC 335.5M
  • BWMX 495.6M
  • IPO Year
  • BNTC N/A
  • BWMX N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • BWMX $13.29
  • Analyst Decision
  • BNTC Strong Buy
  • BWMX Strong Buy
  • Analyst Count
  • BNTC 5
  • BWMX 1
  • Target Price
  • BNTC $26.00
  • BWMX $22.50
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • BWMX 55.5K
  • Earning Date
  • BNTC 09-25-2025
  • BWMX 10-23-2025
  • Dividend Yield
  • BNTC N/A
  • BWMX 10.75%
  • EPS Growth
  • BNTC N/A
  • BWMX N/A
  • EPS
  • BNTC N/A
  • BWMX 0.84
  • Revenue
  • BNTC N/A
  • BWMX $751,432,052.00
  • Revenue This Year
  • BNTC N/A
  • BWMX $6.54
  • Revenue Next Year
  • BNTC N/A
  • BWMX $6.09
  • P/E Ratio
  • BNTC N/A
  • BWMX $15.88
  • Revenue Growth
  • BNTC N/A
  • BWMX 4.83
  • 52 Week Low
  • BNTC $8.06
  • BWMX $7.00
  • 52 Week High
  • BNTC $17.15
  • BWMX $14.46
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • BWMX 62.09
  • Support Level
  • BNTC $12.57
  • BWMX $13.06
  • Resistance Level
  • BNTC $13.33
  • BWMX $13.50
  • Average True Range (ATR)
  • BNTC 0.60
  • BWMX 0.45
  • MACD
  • BNTC 0.10
  • BWMX -0.13
  • Stochastic Oscillator
  • BNTC 95.59
  • BWMX 66.64

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

Share on Social Networks: